LUMIRADX LTD

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch LUMIRADX LTD and buy or sell other stocks, ETFs, and their options commission-free!

About LMDXF

LumiraDX Ltd. is a point of care diagnostics company, which engages in the provision of a diagnostic platform that supports tests with lab-comparable performance at the point of care. The company was founded by Ronald Zwanziger, David Scott, and Jerry McAleer in 2014 and is headquartered in Waltham, MA. 

CEO
Veronique Yvonne Ameye, EMBA; Ian Cowie
CEOVeronique Yvonne Ameye, EMBA; Ian Cowie
Employees
Employees
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2014
Founded2014
Employees
Employees

LMDXF Key Statistics

Market cap
3.62M
Market cap3.62M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
908.10K
Average volume908.10K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.3059
52 Week high$0.3059
52 Week low
52 Week low

Stock Snapshot

With a market cap of 3.62M, LUMIRADX LTD(LMDXF) trades at $0.01.

On 2026-02-02, LUMIRADX LTD(LMDXF) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for LUMIRADX LTD(LMDXF) stock has reached 0, versus its average volume of 908.1K.

People also own

Based on the portfolios of people who own LMDXF. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.